Rheumatoid Arthritis Treated With Implanted Cells That Release Drug

Share This Story, Choose Your Platform!

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. Read more…